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Congenital heart disease (CHD) is one of the most common birth defects, and recent
studies indicate cilia-related mutations play a central role in the genetic etiology of CHD.
As cilia are also known to have important roles in kidney development and disease, it
is not surprising that renal anomalies were found to be enriched among CHD mutant
mice recovered in a large-scale mouse forward genetic screen. Indeed 42% of mutations
identified to cause both CHD and renal anomalies were cilia-related. Many of these
cilia mutations comprise cilia transition zone or inversin compartment components,
consistent with the known role of these cilia proteins in a wide variety of ciliopathies. The
high prevalence of CHDwith congenital anomalies of the kidney and urinary tract (CAKUT)
observed in mice was also corroborated with clinical studies that showed 20–30% of
CHD patients have renal anomalies. Together these findings suggest CHD patients may
benefit from early screening for renal anomalies to allow early diagnosis and intervention
to improve outcome for this vulnerable patient population.
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Congenital heart disease (CHD) is the most common birth defect, occurring in up to 1% of live
births (1). Interestingly, CHD often presents in combination with extra cardiac defects including
congenital anomalies of the kidney and urinary tract (CAKUT) (2–4). In fact, renal or urinary
system defects are associated with 23.1% of congenital heart defects (5). These findings suggest an
overlapping genetic etiology for CHD and CAKUT. Consistent with this is the fact that several
previously reported mouse models (not individually discussed in this review) have found genetic
disruption of a single gene can affect both heart and kidney development, and that many genetic
syndromes can present with both cardiac and renal anomalies (6–9). Hence, insights into the
genetic etiology of CHD may help elucidate the etiology of CAKUT. Relevant to this is the recent
unexpected finding from a large-scale forward genetic screen in mice indicating a significant role
for cilia-related mutations in the pathogenesis of CHD (10). As cilia mutations are well-described
in the context of CAKUT, this would suggest cilia defects may have a central role in mediating both
CHD and CAKUT phenotypes. Below, we briefly discuss CAKUT and its association with CHD,
and its shared genetic etiology involving cilia-related mutations.
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ASSOCIATION OF HEART AND KIDNEY
PHENOTYPES IN GENETIC SYNDROMES
CAKUT represent a broad range of kidney and urinary tract
defects. This can include abnormalities in the shape, size,
or structure of the kidney including kidney agenesis, kidney
hypoplasia or dysplasia, horseshoe/fused kidney, cystic kidneys,
or duplex/multiplex kidney, and multiple collecting ducts or
ureters (11). These defects can occur in combination such as
with the finding of cystic dysplastic kidneys. These structural
abnormalities can result in vesicoureteral reflux, ureteropelvic
junction obstruction, hydroureter, and hydronephrosis (10, 12).
In humans, monogenic mutations in several genes have been
implicated in CAKUT development; however, these mutations
explain only 5–20% of patient disease (13). Additional causes
of CAKUT phenotypes include genetic syndromes, which can
present with a spectrum of phenotypes often involving defects in
many organs including both the heart and the kidney.
In DiGeorge syndrome, heterozygous deletion of
chromosome 22q11.2 is associated with multiple organ
defects, including the heart, the kidney, the thymus, and the
nervous system. It has an estimated prevalence of 1:3,000 to
1:4,000 live births, though prenatal chromosomal analysis
suggests this may be an underestimate, and affected patients
characteristically present with CHD, thymus hypoplasia or
agenesis, and craniofacial defects (14–16). Approximately
20–30% of DiGeorge syndrome patients also exhibit CAKUT
(17). Haploinsufficiency of TBX1, a transcription factor within
the T-box family, has been shown to contribute to the cardiac
phenotypes associated with this disorder (18, 19). More recently,
FIGURE 1 | Ciliary localization of proteins that when mutated cause congenital heart disease recovered from a large-scale screen. Mutations in several of these
proteins can also cause CAKUT. Adapted from Damerla et al. (31).
another gene within the 22q11.2 locus, CRKL, an adaptor protein
that regulates tyrosine kinase signaling, was found to contribute
to developmental kidney defects in the context of DiGeorge
syndrome (20, 21).
Another syndrome known as VACTERL association
also presents with both congenital heart defects and renal
abnormalities. Occurring in 1:10,000 to 1:40,000 live births,
VACTERL association is a birth defect associated with at least
3 of the following phenotypes: vertebral defects, anal atresia,
cardiac defects, trachea-esophageal fistula, renal defects, and
limb defects (22). In a large study of patients diagnosed with
VACTERL association, 80% exhibited kidney defects and
48% exhibited cardiac defects (23). In humans, several genes
have been related to VACTERL association including FGF8,
FOXF1, HOXD13, LPP, TRAP1, and ZIC3, all of which have
been implicated in kidney developmental anomalies, with
ZIC3 being an X-linked gene also shown to cause heterotaxy
(24).
A rarer genetic disorder known as Fraser syndrome can
also cause both CHD and genitourinary abnormalities. It is a
recessive disorder with a prevalence of only 1 in 200,000 (25).
Patients with Fraser syndrome can present with eye defects,
syndactyly, kidney defects, most commonly kidney agenesis,
and heart defects (25). Fraser syndrome is associated with
mutations in FRAS1, FREM2, or GRIP1, all of which are known
to interact to form a FRAS/FREM complex that is localized to
the basement membrane (26, 27). Mutations in these genes cause
loss of the FRAS/FREM complex that likely drives the disease
phenotypes observed in Fraser syndrome, although the precise
disease mechanism remains unclear (27, 28).
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FIGURE 2 | Kidney Phenotypes Observed in Mice with Congenital Heart Disease. Representative examples of the kidney phenotypes observed in mice with
congenital heart disease recovered from a large scale forward genetic screen. Phenotypes can be observed at necropsy and upon H&E staining. Adapted from San
Agustin et al. (10). Control necropsy (Aa) and control H&E stained kidneys (Ab) can be compared with mutant necropsy (Ba,Ca,Da,Ea,F,G) and mutant H&E stained
kidneys (Bb,Cb,Db,Eb, H–J). *represents hydronephrosis.
CILIA AND THE GENETIC LANDSCAPE OF
CHD
The close association of renal anomalies with CHD suggests
insights into the genetics of CHD can yield significant
insights into the mechanism of disease pathogenesis for
CAKUT. Interestingly, the pursuit of a large-scale forward
genetic screen in mice for mutations causing CHD yielded a
large preponderance of mutations in cilia-related genes (29).
From screening more than 100,000 ethylnitrosourea (ENU)
mutagenized mice using in utero fetal ultrasound phenotyping,
we recovered over 200 mouse lines with a wide spectrum
of CHD. Using whole exome sequencing nearly 100 CHD-
causing mutations were recovered in 61 genes, 34 (55.7%) of
which were cilia-related (29). As this is a phenotype driven
mutagenesis screen in which fetal echocardiography was used
to identify mutants with CHD, these findings point to cilia
as playing a central role in the pathogenesis of CHD. This is
corroborated with the completion of the screen, showing over 50
genes are cilia-related among 100 genes recovered causing CHD.
Moreover, analysis of de novo mutations identified in whole
exome sequencing analysis from CHD patients also identified
similar mutations contributing to CHD pathogenesis (30).
CILIA AND CILIOPATHIES IN CHD, RENAL
ANOMALIES, AND OTHER HUMAN
DISEASES
Cilia are microtubule-based organelles that have well-described
compartments including an axoneme that projects from the
apical cell surface, and a basal body base with an overlying
transition zone and inversin compartment that regulate protein
trafficking into and out of the cilium (Figure 1) (32). Cilia can
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TABLE 1 | Renal anomalies associated with genes causing congenital heart defects.
Genea Duplex/multiplex Hydro-nephrosis Cystic Agenesis/Hypoplasia Cardiac phenotype
Anks6* (10) – – 80% – DORV, TGA, AVSD, VSD
Bicc1* (8) – – 100% – DORV, TGA, AVSD, IAA
Cc2d2a* (5) – – 100% – TGA, PTA, DORV, AVSD, Pulmonary Atresia
Cep110 (5) – 60% – – DORV, AVSD, VSD
Cep290* (13) 15% – 100% – DORV, AVSD
Dync2h1* (6) 50% – – – PTA/Pulmonary atresia, VSD, MAPCA
Lrp2 (3) – 100% 100% – PTA, VSD, Ao arch defects
Pkd1 (4) – – 100% – Biventricular Hypertrophy
Ptk7 (3) – – 100% – DORV, VSD, Biventricular Hypertrophy
Tbc1d32* (12) 25% – 92% – PTA, DORV, TGA, AVSD
Tmem67* (12) 42% – 100% – DORV, AVSD, IAA
Adamts6 (16) – 56% – – DORV, OA
Ap1b1* (10) – – 80% – AVSD, VSD, Atrial Isomerism
Ap2b1 (3) – – 75% – DORV/Taussig-Bing, AVSD, VSD, Ao arch defects
Bmp10 (2) – – 100% – DORV
Cxcr4 (5) 60% – – – VSD, Ao atresia, Ao arch defects
Frem2 (10) – – – 100% Biventricular Hypertrophy
Lama5 (5) – – – 60% DORV
Plxnd1 (3) – – – 63% PTA, DORV, AVSD, RAA
Prdm1 (8) 38% – – – DORV, AVSD, VSD, Ao atresia, Ao arch defects
Qrich1 (3) – – – 67% DORV, AVSD, noncompaction
Robo1 (5) 100% (M) – – – VSD, Biventricular Hypertrophy
Slit2 (7) 100% (M) – – – DORV, VSD, Ao arch defects
Snx17 (3) 66% – – – DORV/OA, AVSD
Wnt5a (7) 43% – – – DORV, PTA, AVSD, VSD
Zbtb14 (4) – – 100% – DORV, AVSD, atrioventricular and semilunar valve defects
a Gene with dark highlighting are ciliary components based on proteomic and other studies.
Gene names followed by * indicate mutations that cause situs defects.
Parenthesis indicate the number of mutants analyzed.
Adapted from San Agustin et al. (10).
be motile with the expression of motor dyneins that drive ciliary
motility, or nonmotile, termed primary cilia, which extend from
almost all cell types in the body, including cells of the developing
heart, and are known to serve important cell signaling functions
by mediating various signal transduction processes (33–35).
Motile cilia are required for left-right patterning as well as in
mediating sperm motility, mucociliary clearance in the airway,
and also cerebral spinal fluid flow in the brain. Importantly, it is
now appreciated that cilia mutations can cause a wide spectrum
of human diseases collectively known as ciliopathies (31). Many
of these ciliopathies can present with renal anomalies, such as
in nephronepthesis, Meckel-Gruber syndrome (MKS), Bardet-
Biedl syndrome (BBS), Joubert syndrome, Alstrom syndrome
and polycystic kidney disease among others (36). The renal
defects observed may include CAKUT, polycystic kidney disease
or progressive renal dysfunction. Other structural birth defects
observed in the ciliopathies include CHD, cardiomyopathy,
skeletal malformations, brain abnormalities, blindness, and
obesity (31).
Many of the mutations known to cause renal anomalies
within the ciliopathy spectrum are associated with proteins
localized in the cilia transition zone or inversin compartment.
Thus, among the 61 genes recovered causing CHD, half (N
= 34) were cilia-related, including 11 affecting transition zone
or inversin compartment components (29). While these are
mainly thought to disrupt primary cilia function, recent studies
showed ciliopathies generally considered to involve primary cilia
defects may also impact motile cilia function. This is indicated
by the observation of airway clearance defects in patients
diagnosed with ciliopathies such as Leber congenital amaurosis
or Sensenbrenner syndrome (37, 38). This is not unexpected
given over 70% of proteins required for primary cilia function
are also expressed in motile cilia (39). Indeed, airway clearance
defects are the hallmark of a ciliopathy known as primary ciliary
dyskinesia (PCD).
PCD patients have severe sinopulmonary disease and typically
this is associated with mutations in genes required for motile
cilia function, such as motor dyneins (40–42). It is interesting
to note some isolated reports of bronchiectasis associated with
polycystic kidney disease, although the connection with airway
clearance defects is unknown (43). PCD patients also can
exhibit laterality defects, a reflection of the requirement for
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FIGURE 3 | Mutations in interacting proteins cause a similar spectrum of both heart and kidney phenotypes. Mutations in four interacting proteins, Anks6, Bicc1,
Nek8, and Wwtr1 cause similar phenotypes including both congenital heart disease and cystic kidney disease (Unpublished data).
FIGURE 4 | Kidney Defects Observed in Patients with CHD. Renal ultrasound of patients with congenital heart disease unveils a spectrum of renal abnormalities
including intrarenal collecting system dilation (A–C), cystic-dysplastic abnormalities (D–F), horseshoe kidney (G), and duplicated collecting system depicted with renal
ultrasound (H), and voiding cystourethrogram (I). Adapted from San Agustin et al. (10).
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TABLE 2 | Clinical characteristics of congenital heart disease patients.
ID # Kidney phenotypes Cardiac phenotype* Other phenotypes
7042 Abnormally rotated
kidney, Pelvicaliectasis
HLHS
7199 Caliectasis (dilation of
the renal calices)
HLHS Hypothyroidism
7351 Duplicated collecting
duct system,
Hydronephrosis
HLHS
7208 Duplicated collecting
system, Vesicoureteral
reflux
D-TGA
7319 Ectopic kidney DORV, subaortic VSD
7040 Ectopic kidney,
vesicoureteral reflux
ASD, VSD
7194 Horseshoe kidney TOF, PA
7035 Hydronephrosis ASD, VSD Tethered cord,
hypothyroidism
7288 Mild Hydronephrosis Truncus arteriosus
7053 Pelvicaliectasis D-TGA
7302 Pelvicaliectasis HLHS
7306 Pelvicaliectasis D-TGA
7334 Pelvicaliectasis ASD, VSD, PDA,
Interrupted IVC
7389 Pelvicaliectasis HLHS
7417 Pelvicaliectasis VSD/PDA/ventricular
hypertrophy
7419 Pelvicaliectasis DORV, PA, complete
AVSD, supracardiac
TAPVR
Heterotaxy, asplenia
7430 Pelvicaliectasis Unbalanced AVSD, PA,
supracardiac TAPVR
Heterotaxy, asplenia
7058 Pelvicaliectasis,
Hydroureter
TOF Tethered cord,
exotropia, neurogenic
bladder
7336 Pyelectasis (dilation of
the renal pelvis)
D-TGA
7289 Renal size asymmetry,
Solitary cyst seen by
ultrasound.
HLHS
7474 Unilateral Agenesis HLHS Single testis
7027 Vesicoureteral reflux D-TGA Situs inversus totalis,
seizures
7438 Vesicoureteral reflux HLHS Aspiration,
hypospadias
*D-TGA, D-transposition of the great arteries; DORV, double outlet right ventricle; ASD,
atrial septal defect; VSD, ventricular septal defect; HLHS, hypoplastic left heart syndrome;
TOF, Tetralogy of Fallot; AVSD, atrioventricular septal defect; PA, pulmonary atresia;
TAPVR, total anomalous pulmonary venous return. Adapted from San Agustin et al. (10).
motile cilia in the specification of the left-right body axis
(44, 45). Consistent with this, PCD patients can display a
spectrum of phenotypes including situs solitus (normal visceral
organ situs), situs inversus totalis also known as Kartagener’s
syndrome (reversed visceral organ situs), and heterotaxy, or the
randomization of visceral organ situs. In this context, CHD is
often associated with heterotaxy as a result of defects in motile
cilia function.
Interestingly, some ciliopathies thought to affect only primary
cilia function also can be associated with laterality defects, one
prominent example being MKS, a ciliopathy that causes severe
birth defects and is usually prenatal or neonatal lethal. Studies
of Mks1 mutant mice showed defects involving not only the
primary cilia, but also laterality defects associated with the loss
of motile cilia function in the embryonic node (46). Together,
these findings suggest that the distinction of ciliopathies as either
affecting motile or primary cilia can be problematic, given the
promiscuity of cilia genes in having functional roles in both
primary and motile cilia.
Intriguingly, primary cilia proteins can be found in other
cellular locations, suggesting that they may have other non-
ciliary functions (47). In fact, ciliary proteins are also involved
in a wide range of cellular processes including cell cycle
progression, cytoskeletal organization, and vesicular trafficking
(48–50). Further, cilia themselves are involved in several cell
signaling pathways including the sonic hedgehog, TGFβ, wnt,
and notch pathways, and defects can arise in these pathways
through defective cilia or pathway components outside of the
cilium (51). Thus, future research will be important to determine
the precise roles cilia and cilia associated proteins play in CHD
and CAKUT development.
MUTATIONS CAUSING CHD AND CAKUT
PHENOTYPES
Extra-cardiac phenotypes, including renal anomalies, were
recovered inmany CHDmutantmice even though the screen was
entirely focused on CHD phenotyping. This included a spectrum
of kidney phenotypes including duplex kidney, multiplex kidney,
hydronephrosis, kidney agenesis, and cystic kidney (Figure 2),
with the most commonly observed renal phenotype being duplex
kidneys (10). Among the 39 mutant mouse lines recovered
with congenital kidney abnormalities, the most common CHD
phenotype is double outlet right ventricle (DORV), occurring
in 19/39 lines (48.7%). This is followed by atrioventricular
septal defect, which occurred in 15/39 lines (38.5%; Table 1).
Other CHD phenotypes associated with kidney defects included
transposition of the great arteries (TGA), persistent truncus
arteriosus (PTA), ventricular septal defect (VSD), aortic arch
anomalies, and biventricular hypertrophy (Table 1).
Previous attempts to recover CAKUT genes have been
confounded by incomplete penetrance and the probable
involvement of more complex genetics. The few CAKUT genes
previously identified are largely those that mediate the early
steps in kidney development and patterning. Other than Pax2,
which causes renal coloboma syndrome, andHnf1b, which causes
renal cystic disease and diabetes, most genes identified to cause
CAKUT are associated with disease in only a few patients and
hence, the evidence supporting pathogenesis is limited (52).
Among the 135 CHD mouse lines recovered, 39 (28.8%) had
kidney defects caused by mutations in 26 genes, 11 (42%) being
known cilia genes (Table 1, Figure 1) (10). Remarkably, this
included four cilia genes that encoded known direct protein-
protein interactors: Anks6, Nek8, Bicc1, and Wwtr1 (53–56).
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These mutations were found in four independent CHD mouse
lines, with mutation in each gene causing a similar spectrum of
kidney and heart defect phenotypes comprising double outlet
right ventricle and cystic kidney disease (Figure 3).
CLINICAL STUDY SHOWING
ASSOCIATION OF CHD WITH CAKUT
PHENOTYPES
The relevance of CAKUT abnormalities in CHD was confirmed
with a clinical study of 77 CHD patients recruited from
the Children’s Hospital of Pittsburgh. Retrospective review of
the medical records of these 77 patients revealed 23 (30%)
also had some form of renal defect such as renal cysts,
kidney agenesis, cystic dysplastic kidneys, and horseshoe kidney
(Figure 4, Table 2) (10). These findings are in agreement with
a previous epidemiological study in the Atlanta metro area,
which showed 23% of 8,000 subjects with CHD also had renal
abnormalities (1). Thus, both the mouse and human studies
point to a significant overlap in the genetic etiology of CHD
and kidney abnormalities. This probably reflects the conservation
of developmental pathways and cell signaling mechanisms that
regulate cardiovascular and renal development, including a
central role for cilia in the pathogenesis of CHD and renal birth
defects. Together these findings suggest the routine evaluation of
CHD patients for renal anomalies with simple non-invasive renal
ultrasound may be warranted. This may allow early diagnosis
and early therapeutic intervention to treat and manage any renal
dysfunction that could negatively impact the long-term outcome
of this high-risk patient population.
CONCLUSION
Studies in both CHD mutant mice and CHD patients showed
CAKUT is highly associated with CHD. This is supported by the
finding of CAKUT and CHD in various genetic syndromes, and
the finding that many mutations identified to cause CHD can
also cause CAKUT phenotypes. Among genes identified to cause
both CHD and CAKUT there is a significant enrichment of cilia
genes, indicating a central role for cilia in the pathogenesis of
CHD and CAKUT phenotypes. However, as half of the mutations
identified to cause CHD and renal anomalies are not known to be
cilia-related, the association of CHD with renal anomalies likely
extend beyond the role of cilia in heart and kidney development.
The clinical relevance of these findings in mice were shown with
the observation that 23–30% of CHD patients also exhibited
renal anomalies. This would suggest CHD patients may benefit
from routine evaluation for renal anomalies. This might improve
the long-term outcome of this high-risk patient population by
reducing potential renal complications with early diagnosis and
therapeutic intervention.
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